Analysis of Mean Corpuscular Volume and Red Cell Distribution Width in Patients with Aplastic Anemia

References

• Young NS. Aplastic anemia. N Engl J Med. 2018;379(17):1643–1656.
   PubMed Web of Science ®Google Scholar
• Scheinberg P. A new standard immunosuppression regimen in severe aplastic anemia. N Engl J Med. 2022;386(1):89–90.
   PubMed Web of Science ®Google Scholar
• Durrani J, Groarke EM. Clonality in immune aplastic anemia: mechanisms of immune escape or malignant transformation. Semin Hematol. 2022;59(3):137–142.
   PubMed Web of Science ®Google Scholar
• Scheinberg P, Wu CO, Nunez O, et al. Predicting response to immunosuppressive therapy and survival in severe aplastic anaemia. Br J Haematol. 2009;144(2):206–216.
   PubMed Web of Science ®Google Scholar
• Maner BS, Moosavi L. Mean corpuscular volume. Treasure Island (FL): StatPearls Publishing; 2022.
   Google Scholar
• May JE, Marques MB, Reddy VVB, et al. Three neglected numbers in the CBC: The RDW, MPV, and NRBC count. Cleve Clin J Med. 2019;86(3):167–172.
   PubMed Web of Science ®Google Scholar
• Salvagno GL, Sanchis-Gomar F, Picanza A, et al. Red blood cell distribution width: a simple parameter with multiple clinical applications. Crit Rev Clin Lab Sci. 2015;52(2):86–105.
   PubMed Web of Science ®Google Scholar
• Jia X, Cheng S, Zhang L, et al. Elevated red blood cell distribution width as a poor prognostic factor in patients with hematopoietic stem cell transplantation. Front Oncol. 2020;10:565265.
   PubMed Web of Science ®Google Scholar
• Aktas G, Sit M, Dikbas O, et al. Could red cell distribution width be a marker in Hashimoto’s thyroiditis? Exp Clin Endocrinol Diabetes. 2014;122(10):572–574.
   PubMed Web of Science ®Google Scholar
• Tecer D, Sezgin M, Kanık A, et al. Can mean platelet volume and red blood cell distribution width show disease activity in rheumatoid arthritis? Biomark Med. 2016;10(9):967–974.
   PubMed Web of Science ®Google Scholar
• Ustaoglu M, Aktas G, Avcioglu U, et al. Elevated platelet distribution width and red cell distribution width are associated with autoimmune liver diseases. Eur J Gastroenterol Hepatol. 2021;33(1S Suppl 1):e905–e908.
   PubMedGoogle Scholar
• Aktas G, Alcelik A, Tekce BK, et al. Red cell distribution width and mean platelet volume in patients with irritable bowel syndrome. Prz Gastroenterol. 2014;9(3):160–163.
   PubMedGoogle Scholar
• Aktas G. Hematological predictors of novel Coronavirus infection. Rev Assoc Med Bras. 2021;67(suppl 1):1–2.
   PubMedGoogle Scholar
• Wang J, Erlacher M, Fernandez-Orth J. The role of inflammation in hematopoiesis and bone marrow failure: What can we learn from mouse models? Front Immunol. 2022;13:951937.
   PubMed Web of Science ®Google Scholar
• Li R, Zhou J, Liu Z, et al. Predicting response of severe aplastic anemia to rabbit-antithymocyte immunoglobulin based immunosuppressive therapy combined with Eltrombopag. Front Immunol. 2022;13:884312.
   PubMed Web of Science ®Google Scholar
• Kim SY, Park Y, Kim H, et al. Discriminating myelodysplastic syndrome and other myeloid malignancies from non-clonal disorders by multiparametric analysis of automated cell data. Clin Chim Acta. 2018;480:56–64.
   PubMed Web of Science ®Google Scholar
• Mao X-L, Xi Y-M, Li Z-J, et al. Higher red blood cell distribution width at diagnose is a simple negative prognostic factor in chronic phase-chronic myeloid leukemia patients treated with tyrosine kinase inhibitors. Medicine. 2021;100(10):e24003.
   PubMed Web of Science ®Google Scholar
• Zhou D, Xu P, Peng M, et al. Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma. Clin Chim Acta. 2018;481:34–41.
   PubMed Web of Science ®Google Scholar
• Li M, Xia H, Zheng H, et al. Red blood cell distribution width and platelet counts are independent prognostic factors and improve the predictive ability of IPI score in diffuse large B-cell lymphoma patients. BMC Cancer. 2019;19(1):1084.
   PubMed Web of Science ®Google Scholar
• Miao Y, Zhou X-H, Guo J-J, et al. Association of red blood cell distribution width and outcomes in patients with mantle cell lymphoma. Cancer Med. 2019;8(6):2751–2758.
   PubMed Web of Science ®Google Scholar
• Killick SB, Bown N, Cavenagh J, et al. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016;172(2):187–207.
   PubMed Web of Science ®Google Scholar
• DeZern AE, Churpek JE. Approach to the diagnosis of aplastic anemia. Blood Adv. 2021;5(12):2660–2671.
   PubMed Web of Science ®Google Scholar
• Arber DA, Orazi A, Hasserjian R, et al. The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia. Blood. 2016;127(20):2391–2405.
   PubMed Web of Science ®Google Scholar
• Votavova H, Belickova M. Hypoplastic myelodysplastic syndrome and acquired aplastic anemia: Immune‑mediated bone marrow failure syndromes. Int J Oncol. 2021;60(1):7.
   PubMed Web of Science ®Google Scholar
• , Bono E, McLornan D, Travaglino E, et al. Clinical, histopathological and molecular characterization of hypoplastic myelodysplastic syndrome. Leukemia. 2019;33(10):2495–2505.
   PubMed Web of Science ®Google Scholar
• Fattizzo B, Serpenti F, Barcellini W, et al. Hypoplastic myelodysplastic syndromes: just an overlap syndrome? Cancers. 2021;13(1):132.
   PubMed Web of Science ®Google Scholar
• Baba Y, Saito B, Shimada S, et al. Association of red cell distribution width with clinical outcomes in myelodysplastic syndrome. Leuk Res. 2018;67:56–59.
   PubMed Web of Science ®Google Scholar
• Ogawa S. Clonal hematopoiesis in acquired aplastic anemia. Blood. 2016;128(3):337–347.
   PubMed Web of Science ®Google Scholar
• Podhorecka M, Halicka D, Szymczyk A, et al. Assessment of red blood cell distribution width as a prognostic marker in chronic lymphocytic leukemia. Oncotarget. 2016;7(22):32846–32853.
   PubMedGoogle Scholar
• Montagnana M, Danese E. Red cell distribution width and cancer. Ann Transl Med. 2016;4(20):399.
   PubMed Web of Science ®Google Scholar
• Genovese G, Kähler AK, Handsaker RE, et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N Engl J Med. 2014;371(26):2477–2487.
   PubMed Web of Science ®Google Scholar
• Lee H, Kong S-Y, Sohn JY, et al. Elevated red blood cell distribution width as a simple prognostic factor in patients with symptomatic multiple myeloma. BioMed Res Int. 2014;2014:1–8.
   Web of Science ®Google Scholar
• Wang P-F, Song S-Y, Guo H, et al. Prognostic role of pretreatment red blood cell distribution width in patients with cancer: a meta-analysis of 49 studies. J Cancer. 2019;10(18):4305–4317.
   PubMed Web of Science ®Google Scholar
• Friedman JS, Lopez MF, Fleming MD, et al. SOD2-deficiency anemia: protein oxidation and altered protein expression reveal targets of damage, stress response, and antioxidant responsiveness. Blood. 2004;104(8):2565–2573.
   PubMed Web of Science ®Google Scholar
• Jaiswal S, Fontanillas P, Flannick J, et al. Age-related clonal hematopoiesis associated with adverse outcomes. N Engl J Med. 2014;371(26):2488–2498.
   PubMed Web of Science ®Google Scholar
• Abelson S, Collord G, Ng SWK, et al. Prediction of acute myeloid leukaemia risk in healthy individuals. Nature. 2018;559(7714):400–404.
   PubMed Web of Science ®Google Scholar
• Yoshizato T, Dumitriu B, Hosokawa K, et al. Somatic mutations and clonal hematopoiesis in aplastic anemia. N Engl J Med. 2015;373(1):35–47.
   PubMed Web of Science ®Google Scholar
• Rosenfeld S, Follmann D, Nunez O, et al. Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome. JAMA. 2003;289(9):1130–1135.
   PubMed Web of Science ®Google Scholar
• Sun L, Babushok DV. Secondary myelodysplastic syndrome and leukemia in acquired aplastic anemia and paroxysmal nocturnal hemoglobinuria. Blood. 2020;136(1):36–49.
   PubMed Web of Science ®Google Scholar